A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia

PHASE2TerminatedINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

September 30, 2015

Conditions
Neuralgia, Postherpetic
Interventions
DRUG

AGN-214868

AGN-214868 given as injections into the area of pain on Day 1.

DRUG

AGN-214868 Placebo (Vehicle)

AGN-214868 placebo (vehicle) given as injections into the area of pain on Day 1.

Trial Locations (69)

1090

AKH Wien, Vienna

1160

Wilhelminenspital der Stadt Wien, Vienna

10128

The Medical Research Network, LLC, New York

12627

Berlin Research Centre, Berlin

15366

Facharzt fur Neurologie, Hoppegarten

16602

Allegheny Pain Management, Altoona

24119

Pro scientia med im MARE Klinikum, Kiel

24149

Schmerzklinik Kiel, Kiel

27612

Wake Research Associates, Raleigh

29221

Das Schmerzzentrum Celle, Celle

29406

Clinical Trials of South Carolina, LLC, Charleston

29412

PharmaCorp Clinical Trials, Inc, Charleston

29464

Clinical Research of Charleston, Mt. Pleasant

30060

Drug Studies America, Marietta

32132

Riverside Clinical Research, Edgewater

32806

Compass Research, LLC, Orlando

33602

Regionales Schmerzzentrum DGS, Bielefeld

36039

Schmerz und Palliativzentrum Fulda, Fulda

39104

Magdeburg Research Centre, Magdeburg

44787

Bochum Research Centre, Bochum

48104

Michigan Head Pain and Neurology Institute, Ann Arbor

48334

Quest Research Institute, Farmington Hills

50935

Ambulant study centre, Cologne

55116

Regionales Schmerz- und Palliativ Zentrum DGS Mainz, Mainz

58104

Plains Medical Clinic, Fargo

60596

Frankfurt Research Centre, Frankfurt

61701

Millennium Pain Center, Bloomington

63450

Klinikum Hanau GmbH, Hanau

64114

Center for Pharmaceutical Research, Kansas City

65807

Clinvest Headache Care Center, Springfield

73033

Schmerz und Palliativ- Zentrum Goeppingen, Göppingen

73103

COR Clinical Research, LLC, Oklahoma City

77598

Center for Clinical Studies, Webster

80218

The Mile High Research Center, Denver

80301

Alpine Clinical Research Center, Boulder

81338

Medica Pro Familia Sp. Z.o.o SKA, Gdynia

83713

Injury Care Research, LLC, Boise

85202

Agave Clinical Research, LLC, Mesa

85704

Territory Neurology & Research Institute, Tucson

87109

Albuquerque Neuroscience, Inc., Albuquerque

89081

Universitätsklinik Ulm, Ulm

89518

Neurologische Praxis Heidenheim, Heidenheim

90404

Neurological Research Institute, Santa Monica

92354

Loma Linda University, Loma Linda

92697

University of California, Irvine, Irvine

93710

Neuro-Pain Medical Center, Fresno

95821

Northern California Research Corp, Sacramento

98405

MultiCare Neuroscience Center of Washington, Tacoma

02301

Beacon Clinical Research, Brockton

01104

Springfield Neurology Associates, LLC, Springfield

11803-4491

Island Neurological Associates, P.C., Plainview

02886

Omega Medical Research, Warwick

A-1220

SMZ-Ost Donauspital, Vienna

01307

Leiter des Universitats Schmerz Centrums (USC), Dresden

D-40212

Neuro-Consil GmbH, Düsseldorf

04109

Medamed GmbH, Leipzig

D-04103

Leipzig Research Centre, Leipzig

D-78052

Schmerztherapiezentrum Villingen-Schwenningen, Villingen-Schwenningen

60-773

Poznański Ośrodek Medyczny NOVAMED, Poznan

40-954

Medica Pro Familia Sp. Z.o.o SKA, Katowice

30-510

Malopolskie Centrum Medyczne S.C., Krakow

30-539

Specjalistyczny Gabinet Neurologiczny, Krakow

20-064

Nzoz Neuromed, Lublin

61-853

NZOZ Neuro-Kard, Poznan

70-111

Osrodek Badan Klinicznych Euromedis Sp. z o.o., Szczecin

21-040

Niepubliczny Zaklad Opieki Zdrowotnej, Świdnik

01-231

Przychodnia Specjalistyczna PROSEN, Warsaw

01-868

Medica Pro Familia Warszawa, Warsaw

50-088

Synexus SCM sp. z o.o., Wroclaw

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY